Optic neuropathy by ethambutol in a patient with multiple sclerosis.

Arch Soc Esp Oftalmol (Engl Ed)

Unidad de Neurooftalmología, Servicio de Oftalmología, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Published: January 2022

We present the clinical case of a patient who developed a toxic optic neuropathy due to ethambutol in the context of a tuberculosis reactivation and who also had a personal history of multiple sclerosis. The objective is to highlight the importance of making a good differential diagnosis of this adverse effect and of knowing its main clinical, campimetric and tomographic manifestations and characteristics. Furthermore, since the reversibility of damage is still discussed in the literature, early diagnosis is essential. For this purpose, it is important to inform the patient of the possible symptoms and to carry out an ophthalmological examination and colour tests before starting treatment to assess whether there is progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oftale.2020.12.014DOI Listing

Publication Analysis

Top Keywords

optic neuropathy
8
neuropathy ethambutol
8
multiple sclerosis
8
ethambutol patient
4
patient multiple
4
sclerosis clinical
4
clinical case
4
case patient
4
patient developed
4
developed toxic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!